Chiara Luberto

Dr. Chiara Luberto


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2014 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
Maurizio Del PoetaMaurizio Del Poeta
Maurizio Del Poeta
LNLeonardo Nimrichter
Leonardo Nimrichter
Marcio RodriguesMarcio Rodrigues
Marcio Rodrigues
CLChiara Luberto
Chiara Luberto

1 October 2021 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
JSJustin Snider
Justin Snider
JYJeehyun Karen You
Jeehyun Karen You
XWXia Wang
Xia Wang
Ashley J SniderAshley J Snider
Ashley J Snider
BHBrian Hallmark
Brian Hallmark
FCFloyd (Ski) H. Chilton
Floyd (Ski) H. Chilton
There is an urgent need to identify the cellular and molecular mechanisms responsible for severe COVID-19 that results in death. We initially performed both untargeted and targeted lipidomics as well as focused biochemical analyses of 127 plasma samples and found elevated metabolites associated with secreted phospholipase A2 (sPLA2) activity and mitochondrial dysfunction in patients with severe COVID-19. Deceased COVID-19 patients had higher levels of circulating, catalytically active sPLA2 group IIA (sPLA2-IIA), with a median value that was 9.6-fold higher than that for patients with mild disease and 5.0-fold higher than the median value for survivors of severe COVID-19. Elevated sPLA2-IIA levels paralleled several indices of COVID-19 disease severity (e.g., kidney dysfunction, hypoxia, multiple organ dysfunction). A decision tree generated by machine learning identified sPLA2-IIA levels as a central node in the stratification of patients who died from COVID-19. Random forest analysis and least absolute shrinkage and selection operator–based (LASSO-based) regression analysis additionally identified sPLA2-IIA and blood urea nitrogen (BUN) as the key variables among 80 clinical indices in predicting COVID-19 mortality. The combined PLA-BUN index performed significantly better than did either one alone. An independent cohort (n = 154) confirmed higher plasma sPLA2-IIA levels in deceased patients compared with levels in plasma from patients with severe or mild COVID-19, with the PLA-BUN index–based decision tree satisfactorily stratifying patients with mild, severe, or fatal COVID-19. With clinically tested inhibitors available, this study identifies sPLA2-IIA as a therapeutic target to reduce COVID-19 mortality.

1 March 2013 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
TBTara Ann Burns
Tara Ann Burns
MSMarimuthu Subathra
Marimuthu Subathra
PSPaola Signorelli
Paola Signorelli
YCYoung Choi
Young Choi
XYXiaofeng Yang
Xiaofeng Yang
CLChiara Luberto
Chiara Luberto
Tara Ann Burns, Marimuthu Subathra, Paola Signorelli, Young Choi, Xiaofeng Yang, Yong Wang, Maristella Villani, Kapil Bhalla, Daohong Zhou, Chiara Luberto

1 January 2015 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
ABArielle M. Bryan
Arielle M. Bryan
MPMaurizio Del Poeta
Maurizio Del Poeta
CLChiara Luberto
Chiara Luberto
Fungal infections pose a significant risk for the increasing population of individuals who are immunocompromised. Phagocytes play an important role in immune defense against fungal pathogens, but the interactions between host and fungi are still not well understood. Sphingolipids have been shown to play an important role in many cell functions, including the function of phagocytes. In this review, we discuss major findings that relate to the importance of sphingolipids in macrophage and neutrophil function and the role of macrophages and neutrophils in the most common types of fungal infections, as well as studies that have linked these three concepts to show the importance of sphingolipid signaling in immune response to fungal infections.

1 April 2019 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
JSJustin M. Snider
Justin M. Snider
MTMagali Trayssac
Magali Trayssac
CCChristopher J. Clarke
Christopher J. Clarke
NSNicholas Schwartz
Nicholas Schwartz
ASAshley J. Snider
Ashley J. Snider
YHYusuf Hannun
Yusuf Hannun
Justin M. Snider, Magali Trayssac, Christopher J. Clarke, Nicholas Schwartz, Ashley J. Snider, Lina M. Obeid, Chiara Luberto, Yusuf A. Hannun

1 January 2018 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
JSJustin M. Snider
Justin M. Snider
ASAshley J. Snider
Ashley J. Snider
LOLina M. Obeid
Lina M. Obeid
CLChiara Luberto
Chiara Luberto
YHYusuf Hannun
Yusuf Hannun
Justin M. Snider, Ashley J. Snider, Lina M. Obeid, Chiara Luberto, Yusuf A. Hannun